379 related articles for article (PubMed ID: 34301194)
1. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
Fang T; Liang T; Wang Y; Wu H; Liu S; Xie L; Liang J; Wang C; Tan Y
BMC Gastroenterol; 2021 Jul; 21(1):297. PubMed ID: 34301194
[TBL] [Abstract][Full Text] [Related]
2.
Jin J; Shi Y; Zhang S; Yang S
Acta Oncol; 2020 Jan; 59(1):66-74. PubMed ID: 31545109
[No Abstract] [Full Text] [Related]
3. Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.
Mei ZB; Duan CY; Li CB; Cui L; Ogino S
Ann Oncol; 2016 Oct; 27(10):1836-48. PubMed ID: 27436848
[TBL] [Abstract][Full Text] [Related]
4. Mutation Status of
Kawaguchi Y; Kopetz S; Newhook TE; De Bellis M; Chun YS; Tzeng CD; Aloia TA; Vauthey JN
Clin Cancer Res; 2019 Oct; 25(19):5843-5851. PubMed ID: 31221662
[TBL] [Abstract][Full Text] [Related]
5. Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
Wu Y; Chen C; Hua X; Zhao C; Min H
BMC Cancer; 2024 Apr; 24(1):537. PubMed ID: 38678238
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.
Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K
Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract][Full Text] [Related]
8. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis.
Shang W; Yan C; Liu R; Chen L; Cheng D; Hao L; Yuan W; Chen J; Yang H
BMC Cancer; 2021 Jul; 21(1):770. PubMed ID: 34217244
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.
Roth AD; Delorenzi M; Tejpar S; Yan P; Klingbiel D; Fiocca R; d'Ario G; Cisar L; Labianca R; Cunningham D; Nordlinger B; Bosman F; Van Cutsem E
J Natl Cancer Inst; 2012 Nov; 104(21):1635-46. PubMed ID: 23104212
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Li C; Zuo D; Liu T; Yin L; Li C; Wang L
Gastroenterol Res Pract; 2019; 2019():2391670. PubMed ID: 31933627
[TBL] [Abstract][Full Text] [Related]
13. Clinical meaning of BRAF mutation in Korean patients with advanced colorectal cancer.
Kim B; Park SJ; Cheon JH; Kim TI; Kim WH; Hong SP
World J Gastroenterol; 2014 Apr; 20(15):4370-6. PubMed ID: 24764675
[TBL] [Abstract][Full Text] [Related]
14. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.
Du Y; Zhou X; Huang Z; Qiu T; Wang J; Zhu W; Wang T; Liu P
PLoS One; 2014; 9(10):e110182. PubMed ID: 25333693
[TBL] [Abstract][Full Text] [Related]
17. MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis.
Wu M; Kim YS; Ryu HS; Choi SC; Kim KY; Park WC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
Pathol Res Pract; 2020 Jan; 216(1):152791. PubMed ID: 31866097
[TBL] [Abstract][Full Text] [Related]
18. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
[TBL] [Abstract][Full Text] [Related]
19. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
20. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Huh I; Park T; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Cancer; 2017 Sep; 123(18):3513-3523. PubMed ID: 28513830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
